Last 12 months
Inside the activity.
0 purchase rows · 74 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 11 |
| Dec 2025 | 0 | 7 |
| Jan 2026 | 0 | 6 |
| Feb 2026 | 0 | 6 |
| Mar 2026 | 0 | 9 |
| Apr 2026 | 0 | 2 |
| May 2026 | 0 | 6 |
| Jun 2026 | 0 | 7 |
| Jul 2026 | 0 | 5 |
| Aug 2026 | 0 | 9 |
| Sep 2026 | 0 | 6 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 26, 2024 Filed Jan 29, 2024 22:28 UTC |
LEVY ALAN JDirector
|
SaleCommon Stock | 72 | $370.20 | $26,654.57 |
DisclosureSEC source: 0001035267-24-000013 · edgardoc.xml · nonDerivative · entry 2 LEVY ALAN J · CIK 0001280627 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 25,319 F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on May 8, 2024. F2 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $368.90 to $371.65 as follows: 900 shares sold at $368.90 to $369.78; 600 shares sold at $370.04 to $370.71; and 500 shares sold at $371.60 to $371.65. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| January 26, 2024 Filed Jan 29, 2024 22:28 UTC |
LEVY ALAN JDirector
|
Exercise / conversionCommon Stock | 72 | $154.24 | $11,105.04 |
DisclosureSEC source: 0001035267-24-000013 · edgardoc.xml · nonDerivative · entry 1 LEVY ALAN J · CIK 0001280627 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 25,391 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on May 8, 2024. Read SEC document |
| January 26, 2024 Filed Jan 29, 2024 22:32 UTC |
Curet MyriamEVP & Chief Medical Officer
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 1,500 | $0.00 Strike: $182.83 | $0.00 |
DisclosureSEC source: 0001035267-24-000015 · edgardoc.xml · derivative · entry 6 Curet Myriam · CIK 0001632901 · EVP & Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 1,500 shares Expires 2029-02-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on August 12, 2024. F3 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter. Read SEC document |
| January 26, 2024 Filed Jan 29, 2024 22:32 UTC |
Curet MyriamEVP & Chief Medical Officer
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 2,818 | $0.00 Strike: $177.99 | $0.00 |
DisclosureSEC source: 0001035267-24-000015 · edgardoc.xml · derivative · entry 5 Curet Myriam · CIK 0001632901 · EVP & Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,893 Underlying: Common Stock · 2,818 shares Expires 2030-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on August 12, 2024. F3 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter. Read SEC document |
| January 26, 2024 Filed Jan 29, 2024 22:32 UTC |
Curet MyriamEVP & Chief Medical Officer
|
SaleCommon Stock | 1,500 | $370.15 | $555,221.70 |
DisclosureSEC source: 0001035267-24-000015 · edgardoc.xml · nonDerivative · entry 4 Curet Myriam · CIK 0001632901 · EVP & Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 189 F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on August 12, 2024. F2 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $368.45 to $371.65 as follows: 1,100 shares sold at $368.45 to $369.45; 1.800 shares sold at $369.54 to $370.52; and 1,418 shares sold at $370.65 to $371.65. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| January 26, 2024 Filed Jan 29, 2024 22:32 UTC |
Curet MyriamEVP & Chief Medical Officer
|
Exercise / conversionCommon Stock | 1,500 | $182.83 | $274,249.95 |
DisclosureSEC source: 0001035267-24-000015 · edgardoc.xml · nonDerivative · entry 3 Curet Myriam · CIK 0001632901 · EVP & Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,689 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on August 12, 2024. Read SEC document |
| January 26, 2024 Filed Jan 29, 2024 22:32 UTC |
Curet MyriamEVP & Chief Medical Officer
|
SaleCommon Stock | 2,818 | $370.15 | $1,043,076.50 |
DisclosureSEC source: 0001035267-24-000015 · edgardoc.xml · nonDerivative · entry 2 Curet Myriam · CIK 0001632901 · EVP & Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 189 F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on August 12, 2024. F2 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $368.45 to $371.65 as follows: 1,100 shares sold at $368.45 to $369.45; 1.800 shares sold at $369.54 to $370.52; and 1,418 shares sold at $370.65 to $371.65. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| January 26, 2024 Filed Jan 29, 2024 22:32 UTC |
Curet MyriamEVP & Chief Medical Officer
|
Exercise / conversionCommon Stock | 2,818 | $177.99 | $501,566.52 |
DisclosureSEC source: 0001035267-24-000015 · edgardoc.xml · nonDerivative · entry 1 Curet Myriam · CIK 0001632901 · EVP & Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,007 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on August 12, 2024. Read SEC document |
| December 13, 2023 Filed Dec 14, 2023 17:56 UTC |
Rosa David J.President
|
GiftCommon Stock | 1,572 | $0.00 | $0.00 |
DisclosureSEC source: 0001035267-23-000218 · edgardoc.xml · nonDerivative · entry 1 Rosa David J. · CIK 0001519593 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 154,140 F1 · kind: The filer gifted shares to Venture Christian Church. Read SEC document |
| November 16, 2023 Filed Nov 17, 2023 20:00 UTC |
Curet MyriamEVP & Chief Medical Officer
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 1,500 | $0.00 Strike: $182.83 | $0.00 |
DisclosureSEC source: 0001035267-23-000213 · edgardoc.xml · derivative · entry 9 Curet Myriam · CIK 0001632901 · EVP & Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 9,000 Underlying: Common Stock · 1,500 shares Expires 2029-02-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on August 12, 2024. F3 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter. Read SEC document |
| November 16, 2023 Filed Nov 17, 2023 20:00 UTC |
Curet MyriamEVP & Chief Medical Officer
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 2,819 | $0.00 Strike: $177.99 | $0.00 |
DisclosureSEC source: 0001035267-23-000213 · edgardoc.xml · derivative · entry 8 Curet Myriam · CIK 0001632901 · EVP & Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 10,711 Underlying: Common Stock · 2,819 shares Expires 2030-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on August 12, 2024. F3 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter. Read SEC document |
| November 16, 2023 Filed Nov 17, 2023 20:00 UTC |
Curet MyriamEVP & Chief Medical Officer
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 4,500 | $0.00 Strike: $166.62 | $0.00 |
DisclosureSEC source: 0001035267-23-000213 · edgardoc.xml · derivative · entry 7 Curet Myriam · CIK 0001632901 · EVP & Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,500 shares Expires 2029-08-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on August 12, 2024. F2 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter. Read SEC document |
| November 16, 2023 Filed Nov 17, 2023 20:00 UTC |
Curet MyriamEVP & Chief Medical Officer
|
SaleCommon Stock | 1,500 | $300.00 | $450,000.00 |
DisclosureSEC source: 0001035267-23-000213 · edgardoc.xml · nonDerivative · entry 6 Curet Myriam · CIK 0001632901 · EVP & Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 189 F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on August 12, 2024. Read SEC document |
| November 16, 2023 Filed Nov 17, 2023 20:00 UTC |
Curet MyriamEVP & Chief Medical Officer
|
Exercise / conversionCommon Stock | 1,500 | $182.83 | $274,249.95 |
DisclosureSEC source: 0001035267-23-000213 · edgardoc.xml · nonDerivative · entry 5 Curet Myriam · CIK 0001632901 · EVP & Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,689 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on August 12, 2024. Read SEC document |
| November 16, 2023 Filed Nov 17, 2023 20:00 UTC |
Curet MyriamEVP & Chief Medical Officer
|
SaleCommon Stock | 4,500 | $300.00 | $1,350,000.00 |
DisclosureSEC source: 0001035267-23-000213 · edgardoc.xml · nonDerivative · entry 4 Curet Myriam · CIK 0001632901 · EVP & Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 189 F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on August 12, 2024. Read SEC document |
| November 16, 2023 Filed Nov 17, 2023 20:00 UTC |
Curet MyriamEVP & Chief Medical Officer
|
Exercise / conversionCommon Stock | 4,500 | $166.62 | $749,804.85 |
DisclosureSEC source: 0001035267-23-000213 · edgardoc.xml · nonDerivative · entry 3 Curet Myriam · CIK 0001632901 · EVP & Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,689 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on August 12, 2024. Read SEC document |
| November 16, 2023 Filed Nov 17, 2023 20:00 UTC |
Curet MyriamEVP & Chief Medical Officer
|
SaleCommon Stock | 2,819 | $300.00 | $845,700.00 |
DisclosureSEC source: 0001035267-23-000213 · edgardoc.xml · nonDerivative · entry 2 Curet Myriam · CIK 0001632901 · EVP & Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 189 F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on August 12, 2024. Read SEC document |
| November 16, 2023 Filed Nov 17, 2023 20:00 UTC |
Curet MyriamEVP & Chief Medical Officer
|
Exercise / conversionCommon Stock | 2,819 | $177.99 | $501,744.51 |
DisclosureSEC source: 0001035267-23-000213 · edgardoc.xml · nonDerivative · entry 1 Curet Myriam · CIK 0001632901 · EVP & Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,008 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on August 12, 2024. Read SEC document |
| November 16, 2023 Filed Nov 17, 2023 20:11 UTC |
Johnson Amal MDirector
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 9,567 | $0.00 Strike: $41.26 | $0.00 |
DisclosureSEC source: 0001035267-23-000215 · edgardoc.xml · derivative · entry 3 Johnson Amal M · CIK 0001388397 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,567 shares Expires 2024-04-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on May 1, 2024. F2 · derivative.exercise_date: Non-statutory stock option granted pursuant to the Non-Employee Directors' Stock Option Plan. Option shall vest 100% one year after the date of grant or at the next Shareholders Meeting, whichever should take place first, provided that vesting will cease on termination of the Directors service to the Company. Read SEC document |
| November 16, 2023 Filed Nov 17, 2023 20:11 UTC |
Johnson Amal MDirector
|
SaleCommon Stock | 9,567 | $300.00 | $2,870,100.00 |
DisclosureSEC source: 0001035267-23-000215 · edgardoc.xml · nonDerivative · entry 2 Johnson Amal M · CIK 0001388397 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 11,706 F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on May 1, 2024. Read SEC document |
| November 16, 2023 Filed Nov 17, 2023 20:11 UTC |
Johnson Amal MDirector
|
Exercise / conversionCommon Stock | 9,567 | $41.26 | $394,713.37 |
DisclosureSEC source: 0001035267-23-000215 · edgardoc.xml · nonDerivative · entry 1 Johnson Amal M · CIK 0001388397 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 21,273 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on May 1, 2024. Read SEC document |
| November 14, 2023 Filed Nov 15, 2023 23:44 UTC |
LEVY ALAN JDirector
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 2,000 | $0.00 Strike: $90.49 | $0.00 |
DisclosureSEC source: 0001035267-23-000210 · edgardoc.xml · derivative · entry 3 LEVY ALAN J · CIK 0001280627 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,928 Underlying: Common Stock · 2,000 shares Expires 2027-04-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on May 8, 2024. F2 · derivative.exercise_date: Non-statutory stock option granted pursuant to the Non-Employee Directors' Stock Option Plan. Option shall vest 100% one year after the date of grant or at the next Shareholders Meeting, whichever should take place first, provided that vesting will cease on termination of the Directors service to the Company. Read SEC document |
| November 14, 2023 Filed Nov 15, 2023 23:44 UTC |
LEVY ALAN JDirector
|
SaleCommon Stock | 2,000 | $290.00 | $580,000.00 |
DisclosureSEC source: 0001035267-23-000210 · edgardoc.xml · nonDerivative · entry 2 LEVY ALAN J · CIK 0001280627 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 25,319 F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on May 8, 2024. Read SEC document |
| November 14, 2023 Filed Nov 15, 2023 23:44 UTC |
LEVY ALAN JDirector
|
Exercise / conversionCommon Stock | 2,000 | $90.49 | $180,988.80 |
DisclosureSEC source: 0001035267-23-000210 · edgardoc.xml · nonDerivative · entry 1 LEVY ALAN J · CIK 0001280627 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 27,319 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on May 8, 2024. Read SEC document |
| November 14, 2023 Filed Nov 15, 2023 23:45 UTC |
DeSantis RobertEVP & Chief Strategy & Corp Op
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 597 | $0.00 Strike: $245.60 | $0.00 |
DisclosureSEC source: 0001035267-23-000211 · edgardoc.xml · derivative · entry 6 DeSantis Robert · CIK 0001808942 · EVP & Chief Strategy & Corp Op 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,375 Underlying: Common Stock · 597 shares Expires 2031-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on November 21, 2023. F3 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter. Read SEC document |
| November 14, 2023 Filed Nov 15, 2023 23:45 UTC |
DeSantis RobertEVP & Chief Strategy & Corp Op
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 270 | $0.00 Strike: $242.34 | $0.00 |
DisclosureSEC source: 0001035267-23-000211 · edgardoc.xml · derivative · entry 5 DeSantis Robert · CIK 0001808942 · EVP & Chief Strategy & Corp Op 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 453 Underlying: Common Stock · 270 shares Expires 2030-08-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on November 21, 2023. F2 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter. Read SEC document |
| November 14, 2023 Filed Nov 15, 2023 23:45 UTC |
DeSantis RobertEVP & Chief Strategy & Corp Op
|
SaleCommon Stock | 270 | $290.00 | $78,300.00 |
DisclosureSEC source: 0001035267-23-000211 · edgardoc.xml · nonDerivative · entry 4 DeSantis Robert · CIK 0001808942 · EVP & Chief Strategy & Corp Op 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,259 F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on November 21, 2023. Read SEC document |
| November 14, 2023 Filed Nov 15, 2023 23:45 UTC |
DeSantis RobertEVP & Chief Strategy & Corp Op
|
Exercise / conversionCommon Stock | 270 | $242.34 | $65,430.91 |
DisclosureSEC source: 0001035267-23-000211 · edgardoc.xml · nonDerivative · entry 3 DeSantis Robert · CIK 0001808942 · EVP & Chief Strategy & Corp Op 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,529 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on November 21, 2023. Read SEC document |
| November 14, 2023 Filed Nov 15, 2023 23:45 UTC |
DeSantis RobertEVP & Chief Strategy & Corp Op
|
SaleCommon Stock | 597 | $290.00 | $173,130.00 |
DisclosureSEC source: 0001035267-23-000211 · edgardoc.xml · nonDerivative · entry 2 DeSantis Robert · CIK 0001808942 · EVP & Chief Strategy & Corp Op 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,259 F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on November 21, 2023. Read SEC document |
| November 14, 2023 Filed Nov 15, 2023 23:45 UTC |
DeSantis RobertEVP & Chief Strategy & Corp Op
|
Exercise / conversionCommon Stock | 597 | $245.60 | $146,623.20 |
DisclosureSEC source: 0001035267-23-000211 · edgardoc.xml · nonDerivative · entry 1 DeSantis Robert · CIK 0001808942 · EVP & Chief Strategy & Corp Op 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,856 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on November 21, 2023. Read SEC document |
| November 10, 2023 Filed Nov 13, 2023 22:13 UTC |
Kolli SreelakshmiDirector
|
GrantRestricted Stock Units · Derivative | 240 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001035267-23-000207 · edgardoc.xml · derivative · entry 2 Kolli Sreelakshmi · CIK 0001689392 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 240 Underlying: Common Stock · 240 shares Expires not disclosed F2 · derivative.exercise_date: 100% of the RSUs shall vest on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of Stockholders, subject to the Reporting Person's continued service. F2 · derivative.expiration_date: 100% of the RSUs shall vest on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of Stockholders, subject to the Reporting Person's continued service. Read SEC document |
| November 10, 2023 Filed Nov 13, 2023 22:13 UTC |
Kolli SreelakshmiDirector
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 722 | $0.00 Strike: $277.49 | $0.00 |
DisclosureSEC source: 0001035267-23-000207 · edgardoc.xml · derivative · entry 1 Kolli Sreelakshmi · CIK 0001689392 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 722 Underlying: Common Stock · 722 shares Expires 2030-11-09 F1 · derivative.exercise_date: 100% of the shares subject to the option shall vest on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of Stockholders, subject to the Reporting Person's continued service as a director to the issuer. Read SEC document |
| October 26, 2023 Filed Oct 26, 2023 23:51 UTC |
GUTHART GARY SDirector · CEO
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 33,750 | $0.00 Strike: $49.34 | $0.00 |
DisclosureSEC source: 0001035267-23-000200 · edgardoc.xml · derivative · entry 6 GUTHART GARY S · CIK 0001280628 · Director · CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 33,750 shares Expires 2024-02-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on April 29, 2024. F3 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter. Read SEC document |
| October 26, 2023 Filed Oct 26, 2023 23:51 UTC |
GUTHART GARY SDirector · CEO
|
SaleCommon Stock | 27,385 | $260.11 | $7,123,030.20 |
DisclosureSEC source: 0001035267-23-000200 · edgardoc.xml · nonDerivative · entry 2 GUTHART GARY S · CIK 0001280628 · Director · CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 23,551 F1 · kind: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on April 29, 2024. F2 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $256.16 to $264.24 as follows: 2,409 shares sold at $256.16 to $257.16; 3,572 shares sold at $257.17 to $258.02; 3,090 shares sold at $258.24 to $258.97; 9,133 shares sold at $259.72 to $260.69; 4,304 shares sold at $260.75 to $261.53; 2,750 shares sold at $261.93 to $262.55 and 2,127 shares sold at $264.24. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| October 26, 2023 Filed Oct 26, 2023 23:51 UTC |
GUTHART GARY SDirector · CEO
|
Exercise / conversionCommon Stock | 33,750 | $49.34 | $1,665,336.38 |
DisclosureSEC source: 0001035267-23-000200 · edgardoc.xml · nonDerivative · entry 1 GUTHART GARY S · CIK 0001280628 · Director · CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 50,936 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on April 29, 2024. Read SEC document |
| October 24, 2023 Filed Oct 25, 2023 20:30 UTC |
DeSantis RobertEVP & Chief Strategy & Corp Op
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 564 | $0.00 Strike: $208.90 | $0.00 |
DisclosureSEC source: 0001035267-23-000198 · edgardoc.xml · derivative · entry 9 DeSantis Robert · CIK 0001808942 · EVP & Chief Strategy & Corp Op 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,451 Underlying: Common Stock · 564 shares Expires 2029-08-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on November 21, 2023. F4 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter. Read SEC document |
| October 24, 2023 Filed Oct 25, 2023 20:30 UTC |
DeSantis RobertEVP & Chief Strategy & Corp Op
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 273 | $0.00 Strike: $179.70 | $0.00 |
DisclosureSEC source: 0001035267-23-000198 · edgardoc.xml · derivative · entry 8 DeSantis Robert · CIK 0001808942 · EVP & Chief Strategy & Corp Op 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 633 Underlying: Common Stock · 273 shares Expires 2030-05-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on November 21, 2023. F3 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The grant vests 25% on the first anniversary of the date of grant and monthly thereafter, over a four year period of time. Read SEC document |
| October 24, 2023 Filed Oct 25, 2023 20:30 UTC |
DeSantis RobertEVP & Chief Strategy & Corp Op
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 273 | $0.00 Strike: $177.99 | $0.00 |
DisclosureSEC source: 0001035267-23-000198 · edgardoc.xml · derivative · entry 7 DeSantis Robert · CIK 0001808942 · EVP & Chief Strategy & Corp Op 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 453 Underlying: Common Stock · 273 shares Expires 2030-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on November 21, 2023. F2 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter. Read SEC document |
| October 24, 2023 Filed Oct 25, 2023 20:30 UTC |
DeSantis RobertEVP & Chief Strategy & Corp Op
|
SaleCommon Stock | 564 | $275.00 | $155,100.00 |
DisclosureSEC source: 0001035267-23-000198 · edgardoc.xml · nonDerivative · entry 6 DeSantis Robert · CIK 0001808942 · EVP & Chief Strategy & Corp Op 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,259 F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on November 21, 2023. Read SEC document |
| October 24, 2023 Filed Oct 25, 2023 20:30 UTC |
DeSantis RobertEVP & Chief Strategy & Corp Op
|
Exercise / conversionCommon Stock | 564 | $208.90 | $117,819.60 |
DisclosureSEC source: 0001035267-23-000198 · edgardoc.xml · nonDerivative · entry 5 DeSantis Robert · CIK 0001808942 · EVP & Chief Strategy & Corp Op 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,823 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on November 21, 2023. Read SEC document |
| October 24, 2023 Filed Oct 25, 2023 20:30 UTC |
DeSantis RobertEVP & Chief Strategy & Corp Op
|
SaleCommon Stock | 273 | $271.93 | $74,236.89 |
DisclosureSEC source: 0001035267-23-000198 · edgardoc.xml · nonDerivative · entry 4 DeSantis Robert · CIK 0001808942 · EVP & Chief Strategy & Corp Op 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,259 F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on November 21, 2023. Read SEC document |
| October 24, 2023 Filed Oct 25, 2023 20:30 UTC |
DeSantis RobertEVP & Chief Strategy & Corp Op
|
Exercise / conversionCommon Stock | 273 | $177.99 | $48,590.37 |
DisclosureSEC source: 0001035267-23-000198 · edgardoc.xml · nonDerivative · entry 3 DeSantis Robert · CIK 0001808942 · EVP & Chief Strategy & Corp Op 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,532 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on November 21, 2023. Read SEC document |
| October 24, 2023 Filed Oct 25, 2023 20:30 UTC |
DeSantis RobertEVP & Chief Strategy & Corp Op
|
SaleCommon Stock | 273 | $271.93 | $74,236.89 |
DisclosureSEC source: 0001035267-23-000198 · edgardoc.xml · nonDerivative · entry 2 DeSantis Robert · CIK 0001808942 · EVP & Chief Strategy & Corp Op 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,259 F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on November 21, 2023. Read SEC document |
| October 24, 2023 Filed Oct 25, 2023 20:30 UTC |
DeSantis RobertEVP & Chief Strategy & Corp Op
|
Exercise / conversionCommon Stock | 273 | $179.70 | $49,058.10 |
DisclosureSEC source: 0001035267-23-000198 · edgardoc.xml · nonDerivative · entry 1 DeSantis Robert · CIK 0001808942 · EVP & Chief Strategy & Corp Op 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,532 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on November 21, 2023. Read SEC document |
| October 24, 2023 Filed Oct 26, 2023 23:51 UTC |
GUTHART GARY SDirector · CEO
|
SaleCommon Stock | 2,480 | $271.93 | $674,386.40 |
DisclosureSEC source: 0001035267-23-000200 · edgardoc.xml · nonDerivative · entry 4 GUTHART GARY S · CIK 0001280628 · Director · CEO 10b5-1 filing: Plan reported Ownership: Indirect · by Trust FBO Son Disclosed balance after: 29,840 F1 · kind: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on April 29, 2024. Read SEC document |
| October 24, 2023 Filed Oct 26, 2023 23:51 UTC |
GUTHART GARY SDirector · CEO
|
SaleCommon Stock | 2,480 | $271.93 | $674,386.40 |
DisclosureSEC source: 0001035267-23-000200 · edgardoc.xml · nonDerivative · entry 3 GUTHART GARY S · CIK 0001280628 · Director · CEO 10b5-1 filing: Plan reported Ownership: Indirect · by Trust FBO Daughte Disclosed balance after: 29,840 F1 · kind: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on April 29, 2024. Read SEC document |
| October 10, 2023 Filed Oct 12, 2023 21:18 UTC |
LOEB GARYGeneral Counsel
|
Exercise / conversionRestricted Stock Units · Derivative | 2,613 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001035267-23-000189 · edgardoc.xml · derivative · entry 3 LOEB GARY · CIK 0001561733 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,837 Underlying: Common Stock · 2,613 shares Expires 2026-10-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Each Restricted Stock Unit, granted pursuant to the 2010 Employee Stock Option Plan, represents a contingent right to receive one share of Intuitive Surgical common stock. The grant vests 25% on the first anniversary of the date of grant and annually thereafter, over a four year period of time. Read SEC document |
| October 10, 2023 Filed Oct 12, 2023 21:18 UTC |
LOEB GARYGeneral Counsel
|
Tax withholdingCommon Stock | 904 | $297.83 | $269,238.32 |
DisclosureSEC source: 0001035267-23-000189 · edgardoc.xml · nonDerivative · entry 2 LOEB GARY · CIK 0001561733 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,709 F1 · kind: RSUs vest 25% per year over a four year period, commencing on the first anniversary of the grant date. RSUs convert into common stock on the vest date on a one-for-one basis. 25 % of the shares have been released and a portion of the shares were held back to cover the statutory tax withholding requirements. The net shares were deposited into the holders account. Read SEC document |
| October 10, 2023 Filed Oct 12, 2023 21:18 UTC |
LOEB GARYGeneral Counsel
|
Exercise / conversionCommon Stock | 2,613 | $0.00 | $0.00 |
DisclosureSEC source: 0001035267-23-000189 · edgardoc.xml · nonDerivative · entry 1 LOEB GARY · CIK 0001561733 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,613 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: RSUs vest 25% per year over a four year period, commencing on the first anniversary of the grant date. RSUs convert into common stock on the vest date on a one-for-one basis. 25 % of the shares have been released and a portion of the shares were held back to cover the statutory tax withholding requirements. The net shares were deposited into the holders account. Read SEC document |
| September 14, 2023 Filed Sep 15, 2023 20:39 UTC |
Ladd Amy LDirector
|
SaleCommon Stock | 500 | $305.68 | $152,840.00 |
DisclosureSEC source: 0001035267-23-000186 · edgardoc.xml · nonDerivative · entry 1 Ladd Amy L · CIK 0001781750 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 702 F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on June 14, 2024. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.